Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 15, 2023
[ Wed, Nov 15th 2023
] - WOPRAI
Tue, November 14, 2023
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
[ Tue, Nov 14th 2023
] - WOPRAI
Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $133 on, Nov 14th, 2023
Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $180 to $133 on, Nov 14th, 2023.
Robert has made no other calls on BNTX in the last 4 months.
There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Korn of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Wednesday, November 8th, 2023
- Yifeng Liu of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $111 on, Monday, October 16th, 2023
This is the rating of the analyst that currently disagrees with Robert
- Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $124 on, Friday, July 14th, 2023
